LNK (SH2B3) is a key regulator of integrin signaling in endothelial cells and targets α-parvin to control cell adhesion and migration.
about
ILK: a pseudokinase in the center stage of cell-matrix adhesion and signalingThe ATXN2-SH2B3 locus is associated with peripheral arterial disease: an electronic medical record-based genome-wide association study.Meta-analysis in more than 17,900 cases of ischemic stroke reveals a novel association at 12q24.12.Advantages of Papio anubis for preclinical testing of immunotoxicity of candidate therapeutic antagonist antibodies targeting CD28Association Study of rs3184504 C>T Polymorphism in Patients With Coronary Artery Disease.LNK (SH2B3): paradoxical effects in ovarian cancer.Bortezomib, C1-inhibitor and plasma exchange do not prolong the survival of multi-transgenic GalT-KO pig kidney xenografts in baboonsβ1 integrin signaling maintains human epithelial progenitor cell survival in situ and controls proliferation, apoptosis and migration of their progenyPARVA promotes metastasis by modulating ILK signalling pathway in lung adenocarcinomaThe genetic basis of peripheral arterial disease: current knowledge, challenges, and future directions.Genomic Profile of Chronic Lymphocytic Leukemia in Korea Identified by Targeted Sequencing.Overlap between common genetic polymorphisms underpinning kidney traits and cardiovascular disease phenotypes: the CKDGen consortiumPEDF expression regulates the proangiogenic and proinflammatory phenotype of the lung endothelium.Meta-analyses of four eosinophil related gene variants in coronary heart disease.TIMP-1 modulates chemotaxis of human neural stem cells through CD63 and integrin signalling.α-Parvin, a pseudopodial constituent, promotes cell motility and is associated with lymph node metastasis of lobular breast carcinoma.Integrin-linked kinase mediates force transduction in cardiomyocytes by modulating SERCA2a/PLN function.Peripheral Arterial Disease Genetics: Progress to Date and Challenges Ahead.MR-PheWAS: exploring the causal effect of SUA level on multiple disease outcomes by using genetic instruments in UK Biobank.Statins up-regulate SmgGDS through β1-integrin/Akt1 pathway in endothelial cells.
P2860
Q27001701-18B18691-9A93-4180-8DF3-73F51C2B4250Q29417153-8F2560B1-BC2D-46CD-9E40-88E99A4A96ACQ30410768-B2905DEB-9E70-4A3D-A012-D4726F4CA5D6Q33573593-7F5E250D-2D15-48E9-9A8D-0F7DC89C6BD2Q34221086-31044E1B-02E6-46C2-84A1-B91468DDCB3EQ34302585-939B6378-3FFD-4123-99A1-18111E00BDF4Q35012361-A3C8C097-87C0-4422-86D3-D9C4ECF0498FQ35080919-1D4635F8-8EE6-4E32-B5B5-93E5538ADBC5Q35147563-5D0220DE-7676-4996-BAAB-FB560A72ACE3Q35540524-7BA972FD-9F21-4C92-BDAA-2845A8F3EA97Q36222022-6BA97840-1C1E-41FA-B301-38CAB26891FCQ36863889-73E0D082-8E6A-4609-8BDE-852816D3922CQ37656043-9495F648-6C89-40A1-B4D5-EEB10218C525Q38074824-1ABE5E01-BD51-4EE4-9651-4D36860535CFQ39014784-530D3FCD-A0AF-40CD-A077-621276145965Q39027184-07199351-0F69-42D3-BE0A-925330C0B130Q47816202-04BD6295-9772-4893-A9DA-18BA4A9A427FQ47864520-37791880-5A5D-45F8-8687-69963620C089Q50044432-3B2289ED-4C96-4953-A727-C88BDFEA96A9Q54232373-2917A540-D839-4091-B04A-A82EE0DD62E7
P2860
LNK (SH2B3) is a key regulator of integrin signaling in endothelial cells and targets α-parvin to control cell adhesion and migration.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
LNK (SH2B3) is a key regulator ...... l cell adhesion and migration.
@ast
LNK (SH2B3) is a key regulator ...... l cell adhesion and migration.
@en
type
label
LNK (SH2B3) is a key regulator ...... l cell adhesion and migration.
@ast
LNK (SH2B3) is a key regulator ...... l cell adhesion and migration.
@en
prefLabel
LNK (SH2B3) is a key regulator ...... l cell adhesion and migration.
@ast
LNK (SH2B3) is a key regulator ...... l cell adhesion and migration.
@en
P2093
P2860
P356
P1433
P1476
LNK (SH2B3) is a key regulator ...... ol cell adhesion and migration
@en
P2093
Christopher E Turner
Julie Devallière
Juliette Fitau
Laura Velazquez
Mathias Chatelais
Nathalie Gérard
Philippe Hulin
P2860
P304
P356
10.1096/FJ.11-193383
P407
P577
2012-03-21T00:00:00Z